Pfizer CEO on outlook for monthly GLP-1 injection coming to market
Summary
Pfizer CEO Albert Bourla tells CNBC that the company's GLP-1 drug could appeal to customers looking for a monthly injection, rather than weekly.
Description from CNBC.
Who is covering this
Video coverage
Comments
Comments need JavaScript.